Magnetic Resonance Enterography Assessment of Transmural Healing with Vedolizumab in Moderate to Severe Crohn's Disease: Feasibility in the VERSIFY Phase 3 Clinical Trial.

Jordi RimolaJean-Frédéric ColombelBrian BresslerShashi AdsulJenifer SiegelmanPatricia E ColeDirk LindnerSilvio Danese

Published in: Clinical and experimental gastroenterology (2024)

ClinicalTrials.gov NCT02425111, April 23, 2015, http://www.clinicaltrials.gov NCT02425111; EU Clinical Trials Register EudraCT 2014-003509-13, https://www.clinicaltrialsregister.eu.

Keyphrases

clinical trial
magnetic resonance
phase ii
open label
double blind
high intensity
ulcerative colitis
early onset
study protocol
phase iii
small bowel
patients with inflammatory bowel disease
magnetic resonance imaging
drug induced
randomized controlled trial
computed tomography
placebo controlled